Digital health - April 23, 2026
Karolinska Institutet opens new AI center
The purpose of the Karolinska Institutet Centre for AI Innovation is to serve as a support centre and skills hub.
CDMO - April 23, 2026
CEPI awards seed funding to Analysis Zero
CEPI and the Recipharm company Analysis Zero have announced a new seed collaboration to advance the use of Nuclear Magnetic Resonance (NMR) as a real-time Process Analytical Technology (PAT) for RNA vaccine manufacturing.
In a new job - April 23, 2026
Genmab appoints General Manager Europe and Emerging Markets
The company has appointed Margarida Duarte as General Manager, Europe and Emerging Markets, as the company continues to scale its commercialization presence.
Clinical Trials - April 22, 2026
Hemispherian initiates Phase 1/2a clinical trial
The company has announced the initiation of a first-in-human Phase 1/2a clinical trial of GLIX1 in patients with recurrent and progressive glioblastoma (GBM) and other high-grade gliomas.
Clinical Trials - April 22, 2026
Lytix Biopharma announces Phase II results
The company has announced final efficacy and safety results from its Phase II ATLAS-IT-05 study evaluating intratumoral ruxotemitide (LTX-315) in combination with pembrolizumab in patients with advanced melanoma who have progressed following prior checkpoint inhibitor therapy.
Business Award - April 21, 2026
The winners at Swecare Export Award 2026
Encare will be awarded the Swecare Export Award 2026 and Bioservo will be named a Rising Star.
